Limited Power of Attorney Securities Law
Compliance

The undersigned, as an officer or
director of Endocyte, Inc. (the
"Company"), hereby constitutes and
appoints Michael A. Sherman and Beth A.
Taylor, and each of them, the
undersigned's true and lawful attorney in
fact and agent to complete and execute
such Forms 144, Forms 3, 4 and 5, Form ID
and other forms as such attorney shall in
his or her discretion determine to be
required or advisable pursuant to Rule
144 promulgated under the Securities Act
of 1933 (as amended), Section 16 of the
Securities Exchange Act of 1934 (as
amended) and the rules and regulations
promulgated thereunder, or any successor
laws and regulations, as a consequence of
the undersigned's ownership, acquisition
or disposition of securities of the
Company, and to do all acts necessary in
order to file such forms with the
Securities and Exchange Commission, any
securities exchange or national
association, the Company and such other
person or agency as the attorney shall
deem appropriate.  The undersigned hereby
ratifies and confirms all that said
attorneys in fact and agents shall do or
cause to be done by virtue hereof.

This Limited Power of Attorney shall
remain in full force and effect until the
undersigned is no longer required to file
Forms 144, Forms 3, 4 and 5 or Forms ID
with respect to the undersigned's
holdings of and transactions in
securities issued by the Company unless
earlier revoked by the undersigned in a
writing delivered to the foregoing
attorneys-in-fact.

This Limited Power of Attorney is
executed as of the date set forth below.

/s/ Erik C. Chelius
Signature

Erik C. Chelius
Type or Print Name

Dated:    January 14, 2018


Witness:

/s/ Kathleen Chelius
Signature

Kathleen Chelius
Type or Print Name

Dated:     January 14, 2018

US.115887916.02